2015
DOI: 10.1001/jamaoto.2015.2332
|View full text |Cite
|
Sign up to set email alerts
|

Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma

Abstract: Anaplastic thyroid carcinoma has a grave prognosis, but an aggressive approach, including surgery, chemotherapy, and radiotherapy, seems to improve survival. Higher doses of radiotherapy may have a survival benefit in candidates for palliative treatment and may be considered for patients with extensive disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
39
0
7

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(50 citation statements)
references
References 25 publications
4
39
0
7
Order By: Relevance
“…This difference may explain the more favourable 2-year survival rate in the study of Foote et al when compared to the 2-year-survival rate in our study (8). Aggressive treatment strategies including surgery, chemotherapy and radiotherapy have been suggested to improve survival in patients with ATC (13). This finding agreed well with the result of our study that the use of concurrent chemotherapy in addition to radiotherapy improved survival.…”
Section: Discussionsupporting
confidence: 89%
“…This difference may explain the more favourable 2-year survival rate in the study of Foote et al when compared to the 2-year-survival rate in our study (8). Aggressive treatment strategies including surgery, chemotherapy and radiotherapy have been suggested to improve survival in patients with ATC (13). This finding agreed well with the result of our study that the use of concurrent chemotherapy in addition to radiotherapy improved survival.…”
Section: Discussionsupporting
confidence: 89%
“…In the multivariable analysis, single‐modality treatment was associated with increased risk of death (HR 2.996, 95% CI 1.2‐7.1, P = .013). A smaller series from Israel of 26 patients, evaluating three different RT dose levels showed similar results . Longer median OS was seen with the use of chemotherapy vs none (11 vs 4 months, P = .01), and treatment with chemoradiation vs aggressive palliative RT dose vs conventional palliative RT (11 vs 6 vs 3 months, P < .001).…”
Section: Discussionmentioning
confidence: 71%
“…It is the most lethal form of thyroid malignancies, with a high rate of regional and distant spread and a grave prognosis (2)(3)(4). Primary thyroid lymphoma (PTL) is also an uncommon disease, representing less than 5% of thyroid malignancies.…”
Section: Introductionmentioning
confidence: 99%